"The current lack of effective therapies for high grade gliomas, such as glioblastoma and anaplastic astrocytoma, leaves doctors with few options for treating patients," said Tom Mikkelsen, M.D.,
Farletuzumab is a humanized monoclonal antibody (mAb) that binds to folate receptor alpha (FRA), a cell-surface protein highly expressed in ovarian carcinoma but largely absent from normal tissue.
The approval is conditional solely upon a minor change to the informed consent form that has already been submitted to the FDA. Full approval of the amendment is
Oliceridine is being developed as a potential replacement for currently approved intravenous opioid analgesics. In a recently completed Phase 2 study in postoperative pain, oliceridine matched the analgesic
The program has been initiated today and will be made available to eligible patients in the U.S. and selected European countries diagnosed with relapsed or refractory acute myeloid
It is hoping that the therapy derived from human placenta cell can protect people from radiation exposure, especially those involved in nuclear plant decommissioning. The partnership intends to
The study found that blood levels of two neurotoxic compounds dropped significantly in depressed patients after they were treated with the antidepressant escitalopram (Lexapro). The study, published in
The collaboration is focussed on developing future-generation utrophin modulators for the potential treatment of all patients with the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD). The research
The Department of Oncology at Vejle Hospital, under the leadership of professor Anders Jakobsen and in corporation with Dr. Torben Frøstrup Hansen, has been identified by the collaborators
As a result Nucala is now approved for use in the 31 European countries covered by the European Medicines Agency (EMA). Nucala is the first and only approved
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.